CryoLife reports good results from meniscus study:
This article was originally published in Clinica
CryoLife has reported that results from an eight-year follow-up study back the use of cryopreserved human meniscus cartilage for knee reconstructive surgery. Of 136 patients who had undergone total or partial meniscus replacement surgery using the cryopreserved cartilage, 90% said their surgery had been a success. The study was presented at the American Academy of Orthopaedic Surgeons in San Francisco earlier this month. In 1989, CryoLife initiated a programme for the recovery and cryopreservation of human meniscus tissue. Since then, the Atlanta, Georgia company has provided meniscus tissue to support more than 3,410 implant procedures in the US and Canada.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.